Document is current

Any future updates will be listed below

Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development

Crossref DOI link: https://doi.org/10.1186/s13023-024-03136-7

Published Online: 2024-03-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark